Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
International Journal of Molecular Sciences|December 10, 2021
Phosphodiesterase-4 Inhibition Reduces Cutaneous Inflammation and IL-1β Expression in a Psoriasiform Mouse Model but Does Not Inhibit Inflammasome ActivationBarbara Meier-Schiesser, Mark Mellett, Marigdalia K Ramirez-Fort, et al.
Acta Dermato-Venereologica|April 15, 2021
Differentiating Arteriolosclerotic Ulcers of Martorell from Other Types of Leg Ulcers Based on Vascular HistomorphologyJulia Deinsberger, Jonas Brugger, Philipp Tschandl, et al.
Dermatology (Basel, Switzerland)|July 29, 2024
Fast Itch Relief during Dupilumab Predicts Clinical Efficacy in Bullous Pemphigoid: A Retrospective Cohort StudyJeivicaa Thevan, Eloi Schmauch, Jakob Nilsson, et al.
The Journal of Investigative Dermatology|November 6, 2018
Culprit Drugs Induce Specific IL-36 Overexpression in Acute Generalized Exanthematous PustulosisBarbara Meier-Schiesser, Laurence Feldmeyer, Dragana Jankovic, et al.
JAMA Dermatology|May 28, 2020
Secukinumab Therapy for Netherton SyndromeIsabelle Luchsinger, Nicole Knöpfel, Martin Theiler, et al.
International Journal of Molecular Sciences|September 14, 2024
Distinct Variations in Gene Expression and Cell Composition across Lichen Planus SubtypesCadri Knoch, Veronika Baghin, Patrick Turko, et al.
The Journal of Clinical Investigation|December 6, 2019
IL-36γ drives skin toxicity induced by EGFR/MEK inhibition and commensal Cutibacterium acnesTakashi K Satoh, Mark Mellett, Barbara Meier-Schiesser, et al.
Cell Death & Disease|March 23, 2025
LL37 complexed to double-stranded RNA induces RIG-I-like receptor signalling and Gasdermin E activation facilitating IL-36γ release from keratinocytesJennifer Keller, Judit Danis, Isabella Krehl, et al.
The Journal of Investigative Dermatology|July 17, 2024
Tebentafusp Induces a T-Cell-Driven Rash in Melanocyte-Bearing Skin as an Adverse Event Consistent with the Mechanism of ActionJessica C Hassel, Sarah Stanhope, Alexander Greenshields-Watson, et al.
Cancers|June 26, 2025
Immune-Related Cutaneous Adverse Events Display Distinct Clinical and Molecular Characteristics, Depending on Immune Checkpoints TargetedLukas Kraehenbuehl, Nicola Winkelbeiner, Patrick Turko, et al.
Pageof 4